Replimune Group Inc logo

Replimune Group Inc

REPL
Healthcare|Biotechnology|USA
$10.99
-0.12 (-1.08%)
Tangible Book
$2.01
Earnings Power
$1.15

Analyst Estimates

annual
{ "date": [ "202703", "202803", "202903", "203003", "203103" ], "revenue_estimate": [ 18.28, 112.54, 137.62, 230.94, 349.83 ], "ebit_estimate": [ -229.24, -113.3, -47.93, 1.65, -36.2 ], "ebitda_estimate": [ null, null, null, null, null ], "net_income_estimate": [ -222.34, -148.03, -45.4, 0.76, -39.63 ], "per_share_eps_estimate": [ -1.97, -0.91, -0.54, -0.03, -0.36 ], "eps_nri_estimate": [ -2.21, -1.19, -0.54, -0.03, -0.36 ], "dividend_estimate": [ null, 1, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null ], "pretax_income_estimate": [ -176.32, -148.03, -76.46, -45.96, -39.63 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null ], "gross_margin_estimate": [ null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0 ], "long_term_growth_rate_mean": 45.69, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 46.51, "future_eps_nri_estimate_growth": 45.69, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": 47.27, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 46.25, "future_pretax_income_estimate_growth": 35.71, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ 0.62, 1.32, 10.88, 13.77, 31.9, 35.9, 39.8, 43.3 ], "ebit_estimate": [ -59.85, -58.77, -50.97, -50.51, -65.43, -66.08, -66.74, null ], "ebitda_estimate": [ null, null, null, null, null, null, null, null ], "net_income_estimate": [ -59.58, -58.59, -50.88, -50.4, -65.95, -66.65, -67.37, null ], "per_share_eps_estimate": [ -0.6, -0.59, -0.51, -0.48, -0.33, -0.31, -0.29, -0.27 ], "eps_nri_estimate": [ -0.6, -0.59, -0.53, -0.51, -0.41, -0.4, -0.39, -0.34 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ -58.18, -57.71, -49.82, -150.77, -65.95, -66.65, -67.37, null ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null, null ], "gross_margin_estimate": [ null, null, null, null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 45.69, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 46.51, "future_eps_nri_estimate_growth": 45.69, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": 47.27, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 46.25, "future_pretax_income_estimate_growth": 35.71, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

News

2026-06-30 13:33:49
2026-06-30 11:32:12
2026-06-26 16:25:37
2026-06-26 13:02:01
2026-06-26 12:25:38